Optimal involvement of palliative care (PC) services in the management of patients with
decompensated cirrhosis and end‐stage liver disease (ESLD) is limited. This may result …

Background: Patients with end-stage liver disease (ESLD) have a life-limiting illness that
causes multiple distressing symptoms and negatively affects quality of life (QOL). This …

Despite the resounding benefits of palliative care for patients with other advanced diseases,
palliative care remains underutilized in liver disease. There is an urgent need for education …

End-stage liver disease (ESLD) is the culmination of progression of chronic liver disease to
cirrhosis, decompensation, and chronic liver failure, featuring portal hypertension or …

End‐stage liver disease (ESLD) is associated with a high degree of morbidity and mortality
as well as symptom burden. Despite this, the rate of consultation with palliative care (PC) …

The mortality rate from chronic liver disease in the UK is rising rapidly, and patients with
advanced disease have a symptom burden comparable to or higher than that experienced …

As the final common end point in patients with chronic liver disease of a variety of causes,
end-stage liver disease (ESLD) poses an important clinical challenge. Epidemiologic factors …

Palliative care (PC) is defined as ''patient and familycentered care that optimizes quality of
life by anticipating, preventing, and treating suffering''and should be considered for patients …

Individuals with advanced liver disease (AdvLD), such as decompensated cirrhosis (DC)
and hepatocellular carcinoma (HCC), have significant palliative needs. However, little …

Decompensated cirrhosis is an illness that causes tremendous suffering. The incidence of
cirrhosis is increasing and rates of liver transplant, the only cure, remain stagnant. Palliative …